About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 305 record(s)
Req # A-2019-001696
Adverse Reaction Reports (AERs). Report numbers: E2B_02764833, E2B_02764834, E2B_02764835.Organization: Health Canada
October 2021
Req # A-2020-000024
Adverse Drug Reactions (ADRs). Report numbers: 000725270, 000727919, E2B_02839242, E2B_02936690, E2B_02841776, 000728979 E2B_02494853, 000728983, E2B_02686991, E2B_02772399, E2B_02772420, E2B_02751816, E2B_02589608, E2B_02589610, E2B_02589611.Organization: Health Canada
October 2021
Req # A-2020-000047
Adverse Drug Reactions (ADRs) for Methadone. Report numbers: 587985, 596740, E2B_00004157, E2B_00399841, E2B_00392121, E2B_00406623.Organization: Health Canada
October 2021
Req # A-2020-000069
Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02499848, E2B_02354274, E2B_02521654, E2B_02504642, E2B_02522835, E2B_02589109, E2B_02537231, E2B_02537438, E2B_02590587, E2B_02590405, E2B_02552446, E2B_02613627,…Organization: Health Canada
October 2021
Req # A-2020-000096
Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02886602, E2B_02886636, E2B_02886644, E2B_02886708, E2B_02886732, E2B_02886838, E2B_02887007, E2B_02887156, E2B_02141921, E2B_02887340, E2B_02887420, E2B_02887421,…Organization: Health Canada
October 2021
Req # A-2020-000097
Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02886232, E2B_02886234, E2B_02885673, E2B_02885686, E2B_02885747, E2B_02885683, E2B_02886149, E2B_02846572, E2B_02889912, E2B_02846849, E2B_02892262, E2B_02890129,…Organization: Health Canada
October 2021
Req # A-2020-000222
Adverse Drug Reactions (ADRs) for KEYTRUDA. Report numbers: 000662315, 000673530, 000675563, 000676787, E2B_00518420.Organization: Health Canada
October 2021
Req # A-2020-000522
Adverse Drug Reactions (ADRs) for DOCETAXEL. Report numbers: E2B_02876421, E2B_02829823, E2B_02876627, E2B_02831697, E2B_02922884, E2B_02961718, E2B_02833037, 733189, 736793.Organization: Health Canada
October 2021
Req # A-2020-000576
Adverse Drug Reactions (ADRs). Report numbers: E2B_03035077, 000909156, E2B_02703203, 000910025, E2B_02753876, E2B_03081044, E2B_03082549, E2B_03083944, 000916007.Organization: Health Canada
October 2021
Req # A-2020-000666
Adverse Drug Reactions (ADRs) for PANTOPRAZOLE. Report numbers: 000910313, 000912704, E2B_03071620, E2B_03073247, E2B_03074325, E2B_03084955, E2B_03089070, E2B_03089770, E2B_03106484, E2B_03118203, E2B_03123528, E2B_03125928, E2B_03131770,…Organization: Health Canada
October 2021